Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$10.5M in Q2 2026 · −$59.2M over twelve months
Operating cash flow−$8.6M
Capital spending−$1.9M
Free cash flow−$10.5M
Cash conversion cycle11 days
Analysis
In Q2 2026, Heartflow generated −$8.6M of operating cash flow and spent $1.9M on capital projects, leaving free cash flow of −$10.5M. That is $17.6M more than in Q2 2025 (−$28.1M).
Over the twelve months to Jun 30, 2026, operating cash flow was −$52.2M; the largest uses were other investing ($210M), operating cash flow ($52.2M), capital spending ($6.9M); besides operations, cash came from other financing ($215M), shares issued ($8.4M); the cash balance fell by $45.6M.
Operating cash flow was −$8.6M against net income of −$15.7M. The largest differences: stock-based pay +$7.9M, receivables −$7.2M, depreciation & amortization +$1.2M.
Its cash conversion cycle was 11 days (receivables 56 + inventory 0 − payables 45).
Free cash flow
Operating cash flow less capital spending.Latest (Q2 2026): Operating cash flow −$8.6M, Capital spending $1.9M.
Capital allocation, year by year
Over these 3 years operating cash flow totalled −$199M; the largest uses were operating cash flow ($199M) and net borrowing ($42.4M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$163M
Debtnone
Net cash$163M
Cash runway2.7 years
Heartflow is burning cash: its operations consume cash, a free cash flow of −$59.2M a year at the current rate against $163M of cash and investments: a runway of about 2.7 years before any new financing.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q2 2026
56
—
45
11
Q1 2026
56
—
39
17
Q4 2025
54
—
23
30
Q3 2025
57
—
16
41
Every quarter
Quarter
Operating cash flow
Capital spending
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q2 2026
−$8.6M
−$1.9M
—
$3.2M
−$14.7M
−$10.5M
Q1 2026
−$30.1M
−$1.9M
—
$6.6M
$25.1M
−$32.0M
Q4 2025
−$10.6M
−$1.9M
—
$460K
$246M
−$12.5M
Q3 2025
−$3.0M
−$1.2M
−$44K
$1.0M
−$211M
−$4.2M
Q2 2025
−$27.3M
−$790K
−$1.0M
$852K
$29.6M
−$28.1M
Q1 2025
−$13.2M
−$1.1M
$73.9M
$578K
−$58.4M
−$14.3M
Q4 2024
−$14.0M
−$332K
—
$1.4M
$13.3M
−$14.4M
Q3 2024
−$10.3M
−$1.0M
—
$1.5M
$10.7M
−$11.3M
Heartflow: income statement and cash flow
Heartflow, Q2 2026: revenue $64.1M (+48% year over year), operating margin -27.9%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.